|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 | |
网站主页 >> 化工产品目录 >> alpha-三氮唑核苷>> 市场分析报告 |
alpha-三氮唑核苷市场分析报告 |
|
Achillion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... the treatment of hepatitis C, the interferon-alpha based products from Roche ( ... compete with the interferon and ribavirin based drugs in development, such as ... Valeants ribavirin analog (Viramidine) and Human Genome ... SciClone Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... The company's brand of thymalfasin or thymosin alpha 1 and its primary product, ... of SCV-07 as a monotherapy or in combination with ribavirin in noncirrhotic patients with genotype ... with pegylated interferon and ribavirin. Other: The company has in- ... Amarillo Biosciences Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... influenza, using natural human interferon alpha that is administered in a proprietary low ... therapy with pegylated interferon plus ribavirin. The company has also ... technology relating to the production of interferon alpha-containing lozenges by which the ... Anadys Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... of ANA598 in combination with pegylated interferon-alpha and ribavirin. ANA773: The company develops ... Merck & Co. Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... treatment of HIV infection; and Rebetol (ribavirin, USP) Capsules and Oral Solution ... in combination with PegIntron or Intron A (interferon alpha-2b, recombinant) for treating chronic hepatitis ... Hepatitis C Virus And Therapeutics: Market Research Report This report analyzes the worldwide markets for Hepatitis C Virus And Therapeutics in US$ Millions. Annual forecasts are provided for each region for the period of 2006 through 2015. The report profiles 123 companies including many key and niche players ... Global Pediatric Respiratory Syncytial Virus Infection Market 2023 by Company, Regions, Type and Application, Forecast to 2029 ... markets. Market segment by Type Bronchodilators Alpha agonists Ribavirin Market segment by Application Hospital ... Global Pediatric Respiratory Syncytial Virus Infection Supply, Demand and Key Producers, 2023-2029 ... Infection Market, Segmentation by Type Bronchodilators Alpha agonists Ribavirin Global Pediatric Respiratory Syncytial ... Global Pediatric Respiratory Syncytial Virus Infection Market Growth (Status and Outlook) 2023-2029 ... . Market Segmentation: Segmentation by type Bronchodilators Alpha agonists Ribavirin Segmentation by application Hospital Pharmacies ... KOL Insight: Hepatitis C: the Race for the First Interferon-free Regimen Analyzing the Hepatitis C Market Landscape After more than a decade of limited treatment options, the hepatitis C (HCV) market is on the cusp of a treatment revolution. In 2011, protease inhibitors-Incivek (telaprevir; Vertex) and Victrelis (boceprevir; ... Hepatitis C: Game changing regimens to revolutionise treatment landscape - KOL Insight Approval of Gilead’s once daily oral nucleotide inhibitor Sovaldi marks a significant step in the treatment of hepatitis C (HCV). With efficacy over 90% in GT1/2/3/4 patients, this safe, best in class therapy represents a paradigm shift compared to the ... 2020 COVID-19 Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ... , Alkaline phosphatase, Almitrine, alpha-Interferon, Alteplase, Ambrisentan, ... , Remestemcel-L, RESP301, resveratrol, Ribavirin, RITONAVIR, Ritonavir , Rivaroxaban, ... , Thymalfasin, Thymoquinone, Thymosin Alpha 1 , Tinzaparin , Tirofiban, TJ003234, TL- ... COVID-19 Therapy and Vaccine Drug Pipeline and Clinical Trials Report- September 2020 Update ... , Alkaline phosphatase, Almitrine, alpha-Interferon, Alteplase, Ambrisentan, ... , Remestemcel-L, RESP301, resveratrol, Ribavirin, RITONAVIR, Ritonavir , Rivaroxaban, ... , Thymalfasin, Thymoquinone, Thymosin Alpha 1 , Tinzaparin , Tirofiban, TJ003234, TL- ... COVID-19 Impact on Vaccines & Drugs Market - Global Forecast to 2025 ... countries, as well as old antivirals ribavirin and interferon-alpha. Similarly, Avigan (favipiravir) by Fujifilm ... Hepatitis C - Pipeline Insight, 2021 ... evaluation in combination with DAG181 and Ribavirin for 12 weeks of treatment in HCV Genotype ... Research programme: antiviral vaccines IFN alpha CS(g) Global Pediatric Respiratory Syncytial Virus Infection Market Research Report 2025(Status and Outlook) ... Nordic Market Segmentation (by Type) Bronchodilators Alpha agonists Ribavirin Market Segmentation (by Application) Hospital ... Arbovirus Infection Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast ?2024-2034? ... utilization of efficacious antiviral medications, such as ribavirin, interferon-alpha, and various other supportive ... Competitor Analysis: Targeted Therapy of Hepatitis C ... interferon alpha (peg-IFN-alpha) therapy has been supplemented with ribavirin. ... Combination therapy with peg-IFN-alpha and ribavirin has resulted in a further increase ... agents. Moreover, pegylated IFN alpha and/or ribavirin are associated with frequent ... |